These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 14749503)

  • 1. Obesity, insulin resistance, and cardiovascular disease.
    Reaven G; Abbasi F; McLaughlin T
    Recent Prog Horm Res; 2004; 59():207-23. PubMed ID: 14749503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance: the link between obesity and cardiovascular disease.
    Reaven GM
    Med Clin North Am; 2011 Sep; 95(5):875-92. PubMed ID: 21855697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals.
    Reaven G
    Diab Vasc Dis Res; 2005 Oct; 2(3):105-12. PubMed ID: 16334591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals.
    McLaughlin T; Allison G; Abbasi F; Lamendola C; Reaven G
    Metabolism; 2004 Apr; 53(4):495-9. PubMed ID: 15045698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of metabolic markers to identify overweight individuals who are insulin resistant.
    McLaughlin T; Abbasi F; Cheal K; Chu J; Lamendola C; Reaven G
    Ann Intern Med; 2003 Nov; 139(10):802-9. PubMed ID: 14623617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance: the link between obesity and cardiovascular disease.
    Reaven GM
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):581-601, vii-viii. PubMed ID: 18775353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of identifying the overweight patient who will benefit the most by losing weight.
    Reaven GM
    Ann Intern Med; 2003 Mar; 138(5):420-3. PubMed ID: 12614095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between insulin resistance and cardiovascular risk factors in overweight/obese non-diabetic Asian adults: the 1992 Singapore National Health Survey.
    Lim SC; Tan BY; Chew SK; Tan CE
    Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1511-6. PubMed ID: 12439654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin resistance syndrome: definition and dietary approaches to treatment.
    Reaven GM
    Annu Rev Nutr; 2005; 25():391-406. PubMed ID: 16011472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women.
    McLaughlin T; Abbasi F; Kim HS; Lamendola C; Schaaf P; Reaven G
    Metabolism; 2001 Jul; 50(7):795-800. PubMed ID: 11436184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
    McLaughlin T; Abbasi F; Lamendola C; Reaven G
    Arch Intern Med; 2007 Apr; 167(7):642-8. PubMed ID: 17420421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
    Clifton PM; Bastiaans K; Keogh JB
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origin of cardiovascular risk in overweight preschool children: a cohort study of cardiometabolic risk factors at the onset of obesity.
    Shashaj B; Bedogni G; Graziani MP; Tozzi AE; DiCorpo ML; Morano D; Tacconi L; Veronelli P; Contoli B; Manco M
    JAMA Pediatr; 2014 Oct; 168(10):917-24. PubMed ID: 25111132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does metabolic health in overweight and obesity persist? - Individual variation and cardiovascular mortality over two decades.
    Kaur A; Johnston DG; Godsland IF
    Eur J Endocrinol; 2016 Aug; 175(2):133-43. PubMed ID: 27412654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and impaired glucose tolerance in overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2008 Jun; 29(2):123-31. PubMed ID: 18693476
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.